TLR-4 agonistic lipopolysaccharide upregulates interleukin-8 at the transcriptional and post-translational level in vascular smooth muscle cells

Vascular Pharmacology

Volumn 50, Issue 1-2, 2009, Pages 34-39

  Hong, Taek Jong ^a   Ban, Ji Eun ^a   Choi, Kyung Ha ^a   Son, Yong Hae ^a   Kim, Sun Mi ^a   Eo, Seong Kug ^b   Park, Hee Ju ^a   Rhim, Byung Yong ^a   Kim, Koanhoi ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Chonbuk National University   (South Korea)

Author keywords

Interleukin 8; Lipopolysaccharide; Toll like receptor 4; Vascular smooth muscle cell

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CCAAT ENHANCER BINDING PROTEIN; CURCUMIN; EPIGALLOCATECHIN GALLATE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RESVERATROL; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

AORTA; CCAAT-ENHANCER-BINDING PROTEINS; CELLS, CULTURED; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS, GENETIC; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 57149120955     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2008.08.006     Document Type: Article

References (32)

1. Aiyar N., Disa J., Ao Z., Ju H., Nerurkar S., Willette R.N., Macphee C.H., Johns D.G., and Douglas S.A. Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells. Mol. Cell. Biochem. 295 (2007) 113-120
2. Akira S., and Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 4 (2004) 499-511
3. Boisvert W.A., Santiago R., Curtiss L.K., and Terkeltaub R.A. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J. Clin. Invest. 101 (1998) 353-363
4. Brown P.H., Chen T.K., and Birrer M.J. Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene 9 (1994) 791-799
5. Derijard B., Raingeaud J., Barrett T., Wu I.H., Han J., Ulevitch R.J., and Davis R.J. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267 (1995) 682-685
6. DiDonato J., Mercurio F., Rosette C., Wu-Li J., Suyang H., Ghosh S., and Karin M. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16 (1996) 1295-1304
7. Edfeldt K., Swedenborg J., Hansson G.K., and Yan Z.Q. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105 (2002) 1158-1161
8. Gerszten R.E., Garcia-Zepeda E.A., Lim Y.C., Yoshida M., Ding H.A., Gimbrone Jr. M.A., Luster A.D., Luscinskas F.W., and Rosenzweig A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398 (1999) 718-723
9. Ho F.M., Kang H.C., Lee S.T., Chao Y., Chen Y.C., Huang L.J., and Lin W.W. The anti-inflammatory actions of LCY-2-CHO, a carbazole analogue, in vascular smooth muscle cells. Biochem. Pharmacol. 74 (2007) 298-308
10. Hollestelle S.C., De Vries M.R., Van Keulen J.K., Schoneveld A.H., Vink A., Strijder C.F., Van Middelaar B.J., Pasterkamp G., Quax P.H., and De Kleijn D.P. Toll-like receptor 4 is involved in outward arterial remodeling. Circulation 109 (2004) 393-398
11. Huo Y., Weber C., Forlow S.B., Sperandio M., Thatte J., Mack M., Jung S., Littman D.R., and Ley K. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J. Clin. Invest. 108 (2001) 1307-1314
12. Inoue T., Komoda H., Nonaka M., Kameda M., Uchida T., and Node K. Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. Int. J. Cardiol. 124 (2008) 319-325
13. Mansour S.J., Matten W.T., Hermann A.S., Candia J.M., Rong S., Fukasawa K., Vande Woude G.F., and Ahn N.G. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265 (1994) 966-970
14. Michelsen K.S., Wong M.H., Shah P.K., Zhang W., Yano J., Doherty T.M., Akira S., Rajavashisth T.B., and Arditi M. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10679-10684
15. Moreau M., Brocheriou I., Petit L., Ninio E., Chapman M.J., and Rouis M. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: relevance to stability of atherosclerotic plaque. Circulation 99 (1999) 420-426
16. Olive M., Williams S.C., Dezan C., Johnson P.F., and Vinson C. Design of a C/EBP-specific, dominant-negative bZIP protein with both inhibitory and gain-of-function properties. J. Biol. Chem. 271 (1996) 2040-2047
17. Olszanecki R., Jawien J., Gajda M., Mateuszuk L., Gebska A., Korabiowska M., Chlopicki S., and Korbut R. Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. J. Physiol. Pharmacol. 56 (2005) 627-635
18. Peveri P., Walz A., Dewald B., and Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J. Exp. Med. 167 (1988) 1547-1559
19. Rus H.G., Vlaicu R., and Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 127 (1996) 263-271
20. Schroder J.M., and Christophers E. Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. J. Immunol. 142 (1989) 244-251
21. Singh S., and Aggarwal B.B. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J. Biol. Chem. 270 (1995) 24995-25000
22. Son Y.H., Jeong Y.T., Lee K.A., Choi K.H., Kim S.M., Rhim B.Y., and Kim K. Roles of MAPK and NF-kappaB in interleukin-6 induction by lipopolysaccharide in vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 51 (2008) 71-77
23. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., and Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320 (1989) 915-924
24. Tedgui A., and Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 86 (2006) 515-581
25. Wang J.M., Sica A., Peri G., Walter S., Padura I.M., Libby P., Ceska M., Lindley I., Colotta F., and Mantovani A. Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler. Thromb. 11 (1991) 1166-1174
26. Wu Y.M., Robinson D.R., and Kung H.J. Signal pathways in up-regulation of chemokines by tyrosine kinase MER/NYK in prostate cancer cells. Cancer. Res. 64 (2004) 7311-7320
27. Yang X., Coriolan D., Murthy V., Schultz K., Golenbock D.T., and Beasley D. Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling. Am. J. Physiol. Heart. Circ. Physiol. 289 (2005) H1069-H1076
28. Yang X., Murthy V., Schultz K., Tatro J.B., Fitzgerald K.A., and Beasley D. Toll-like receptor 3 signaling evokes a proinflammatory and proliferative phenotype in human vascular smooth muscle cells. Am. J. Physiol. Heart. Circ. Physiol. 291 (2006) H2334-H2343
29. Youn H.S., Lee J.Y., Fitzgerald K.A., Young H.A., Akira S., and Hwang D.H. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J. Immunol. 175 (2005) 3339-3346
30. Youn H.S., Lee J.Y., Saitoh S.I., Miyake K., Kang K.W., Choi Y.J., and Hwang D.H. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea. Biochem. Pharmacol. 72 (2006) 850-859
31. Youn H.S., Saitoh S.I., Miyake K., and Hwang D.H. Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem. Pharmacol. 72 (2006) 62-69
32. Yue T.L., Wang X., Sung C.P., Olson B., McKenna P.J., Gu J.L., and Feuerstein G.Z. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circ. Res. 75 (1994) 1-7